Deshpande; Shailesh
Patent Applications and Registrations
Patent applications and USPTO patent grants for Deshpande; Shailesh.The latest application filed is for "consolidated data restoration framework".
- Deshpande; Shailesh - Pune IN
- Deshpande; Shailesh - Glen Allen VA
- Deshpande; Shailesh - Gandhinagar IN
- Deshpande; Shailesh - Gujrat IN
- Deshpande; Shailesh - Gujarat IN
| Patent | Date |
|---|---|
| Systems and methods for automatically creating an image processing pipeline Grant 11,379,261 - Deshpande , et al. July 5, 2 | 2022-07-05 |
| Consolidated Data Restoration Framework App 20220004465 - Huntley; Christopher Emmanuel ; et al. | 2022-01-06 |
| Systems And Methods For Automatically Creating An Image Processing Pipeline App 20210141663 - DESHPANDE; Shailesh ; et al. | 2021-05-13 |
| Pharmaceutical formulations Grant 10,772,879 - Dutt , et al. Sept | 2020-09-15 |
| Pyridinium compounds Grant 10,717,727 - Dutt , et al. | 2020-07-21 |
| Low dose pharmaceutical composition Grant 10,471,005 - Dutt , et al. Nov | 2019-11-12 |
| Novel Pyridinium Compounds App 20190169175 - DUTT; Chaitanya ; et al. | 2019-06-06 |
| Substituted Fused Pyrimidinone Compounds App 20190127381 - DUTT; Chaitanya ; et al. | 2019-05-02 |
| Pyridinium compounds Grant 10,233,175 - Dutt , et al. | 2019-03-19 |
| Fused imidazobenzothiazole compounds Grant 10,227,361 - Shinde , et al. | 2019-03-12 |
| Novel Fused Imidazobenzothiazole Compounds App 20180127437 - SHINDE; Pundlik ; et al. | 2018-05-10 |
| Urea-substituted indanes as P38 map kinase inhibitors Grant 9,963,463 - Rode , et al. May 8, 2 | 2018-05-08 |
| Novel Pyridinium Compounds App 20180118728 - DUTT; Chaitanya ; et al. | 2018-05-03 |
| Pharmaceutical Formulations App 20180110763 - DUTT; Chaitanya ; et al. | 2018-04-26 |
| Fused imidazobenzothiazole compounds Grant 9,908,898 - Shinde , et al. March 6, 2 | 2018-03-06 |
| P38 Map Kinase Inhibiting Indanyl Urea Compounds App 20170247390 - RODE; Milind ; et al. | 2017-08-31 |
| Low Dose Pharmaceutical Composition App 20170157129 - DUTT; Chaitanya ; et al. | 2017-06-08 |
| Novel Fused Imidazobenzothiazole Compounds App 20170107233 - SHINDE; Pundlik ; et al. | 2017-04-20 |
| Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease Grant 9,610,247 - Dutt , et al. April 4, 2 | 2017-04-04 |
| Use Of A Thiazolo Pyrimidinone For The Treatment Of Inflammatory Bowel Disease App 20160120801 - DUTT; Chaitanya ; et al. | 2016-05-05 |
| Novel Substituted Imidazopyrimidines as Gpbar1 Receptor Modulators App 20150126530 - Dutt; Chaitanya ; et al. | 2015-05-07 |
| Fused thiazolo and oxazolo pyrimidinones Grant 8,822,484 - Srivastava , et al. September 2, 2 | 2014-09-02 |
| Novel Fused Thiazolo And Oxazolo Pyrimidinones App 20130331406 - SRIVASTAVA; Sanjay ; et al. | 2013-12-12 |
| Fused thiazolo and oxazolo pyrimidinones Grant 8,541,430 - Srivastava , et al. September 24, 2 | 2013-09-24 |
| Novel Heterocyclic Compounds App 20120046317 - Dutt; Chaitanya ; et al. | 2012-02-23 |
| Novel Fused Thiazolo And Oxazolo Pyrimidinones App 20110130414 - Srivastava; Sanjay ; et al. | 2011-06-02 |
| Novel Substituted Piperidones as HSP Inducers App 20100190824 - Kumar; Prabhat ; et al. | 2010-07-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 